Detalhe da pesquisa
1.
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
Proc Natl Acad Sci U S A
; 116(36): 17990-18000, 2019 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439820
2.
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.
Br J Cancer
; 124(3): 616-627, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173151
3.
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance.
Int J Cancer
; 142(10): 2139-2152, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29243224
4.
Monitoring a pulse in adults.
Br J Nurs
; 27(21): 1237-1239, 2018 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457372
5.
The therapeutic potential of targeting minimal residual disease in melanoma.
Clin Transl Med
; 13(3): e1197, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967556
6.
PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma.
PLoS One
; 18(11): e0292278, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917641
7.
Inhibition of the MNK1/2-eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer.
Mol Cancer Ther
; 22(2): 192-204, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722142
8.
Modifiable in-hospital factors for 12-month global cognition, post-traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID-19.
Influenza Other Respir Viruses
; 17(9): e13197, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752063
9.
Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?
NPJ Precis Oncol
; 6(1): 26, 2022 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444175
10.
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma.
Nat Commun
; 13(1): 1100, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232962
11.
Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies.
Cancers (Basel)
; 13(22)2021 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830962
12.
Is resistance to targeted therapy in cancer inevitable?
Cancer Cell
; 39(8): 1047-1049, 2021 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375607
13.
Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma.
Front Immunol
; 12: 661737, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34025662
14.
PRMT5: An Emerging Target for Pancreatic Adenocarcinoma.
Cancers (Basel)
; 13(20)2021 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34680285
15.
CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway.
Cancers (Basel)
; 13(3)2021 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33572972
16.
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma.
Cancers (Basel)
; 13(24)2021 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34944961
17.
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625515
18.
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma.
Cancer Immunol Res
; 9(2): 136-146, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33303574
19.
Low SARS-CoV-2 Seroprevalence and No Active Infections among Dogs and Cats in Animal Shelters with Laboratory-Confirmed COVID-19 Human Cases among Employees.
Biology (Basel)
; 10(9)2021 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34571775
20.
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory.
Cancer Discov
; 11(10): 2582-2601, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990344